#1 Stock After New Cancer Vaccine Announcement (NOT Moderna or Merck)

Moderna Doubled in One Day. This Medical Stock Could Be Next

Dear Reader, After the historic cancer vaccine met key goals in Phase 3 trials...   Moderna's stock doubled in a single day. And Merck soared too.   Here's the stock that could be next...   According to a tech expert who helped manage $200 million for billionaire Steve Cohen's fund (owner of the New York Mets)... and who's personally met Elon Musk... the biotech stock that could soar next is NOT Moderna, Merck, or any stock you might expect.   The #1 play right now is a very different kind of company – directly tied into this story.   It holds the key to a new tech that could make Moderna and Merck's accomplishment look small by comparison...   This tech: Is already backed by billionaires Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel. Nvidia CEO Jensen Huang says it's about to have "the most dramatic impact" on our lives. Anthropic's CEO says it could unlock 100 years of medical progress in the next 10 years alone. And its impact on our health could be so dramatic... Nature Magazine says it could be worth $367 trillion to the global economy. This new medical tech is already going live across the United States.   Before you wake up to the next big biotech gain – and miss out...   Click here to learn about the top way to play this new era of biotech and medicine.   Regards,   Whitney Tilson Senior Editor, Stansberry Research   P.S. Remember, Moderna's stock doubled in a single day after one big announcement. That's why you'll want to move fast. Click here to see the next medical stock that could soar. This ad is sent on behalf of Stansberry Research, 1125 N Charles St, Baltimore, MD 21201. Advertising Disclosure: This email contains paid advertisements. This email is from our associates at Stansberry Research. Legal Entity Information: Wealthiest Investor News is owned and operated by Darwin Investor Network, a DBA of The Darwin Agency, Inc. Disclaimer: Nothing in this email should be considered personalized financial advice. Always conduct your own due diligence when investing. We urge you to read our full disclaimer by clicking on the terms of use link below. Unsubscribe: You are receiving this email as part of your complimentary subscription to the Wealthiest Investor News E-Letter. If you would like to unsubscribe, you can do so by clicking on the unsubscribe link below. Darwin Investor Network 2319 N Andrews Avenue, Fort Lauderdale, FL 33311 support@wealthiestinvestornews.com | 1-800-496-9838 Wealthiest Investor News | Privacy Policy | Terms of Use Unsubscribe | View Online

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: